Explore the role of excitatory amino acid transporters (EAATs) in epilepsy treatment and how understanding glutamate clearance could revolutionize therapy for drug-resistant epilepsy.
Exploring the evidence for neurotoxicity in prodromal and early schizophrenia through glutamate dysregulation, neuroinflammation, and blood-brain barrier dysfunction.